MOTS-c: A Mitochondrial-Derived Peptide in Longevity

MOTS-c has become a recurring name in longevity research and in discussions of so-called exercise-mimetic compounds. Part of its appeal is genuinely interesting biology: it is one of a small number of peptides encoded not by the cell’s main genome but by mitochondrial DNA. This article explains what MOTS-c is, how it appears to work, and what the research does and does not currently support.

What MOTS-c Is

MOTS-c stands for Mitochondrial Open Reading Frame of the 12S rRNA type-c. It is a short peptide, 16 amino acids in length, and it was identified in 2015 by a research group at the University of Southern California. Since then it has been studied as a signaling molecule involved in metabolic regulation and cellular stress responses.

A Peptide Encoded by Mitochondrial DNA

The detail that makes MOTS-c scientifically notable is where its genetic instructions live. Most peptides and proteins in the body are encoded by the nuclear genome. MOTS-c is instead encoded within a region of mitochondrial DNA, the small separate genome carried inside mitochondria. Peptides of this kind are called mitochondrial-derived peptides, and only a handful are known.

This matters because it points to a form of biological communication that runs from the mitochondria outward to the rest of the cell, and even to other tissues. Mitochondria are usually described simply as the cell’s power plants; MOTS-c is part of the evidence that they also act as signaling hubs that can influence whole-body metabolism. That framing is what connects MOTS-c to both exercise biology and aging research.

How It Works

AMPK and metabolic regulation

A central part of MOTS-c’s described activity is the AMPK pathway. AMPK is a cellular energy sensor that becomes active when energy is low and shifts the cell toward producing rather than storing energy. Preclinical work indicates MOTS-c activates AMPK and influences metabolic processes, including pathways tied to folate and methionine metabolism and to insulin sensitivity. Under metabolic stress, MOTS-c has also been observed to move into the cell nucleus, where it can influence the expression of stress-response genes.

The exercise connection

MOTS-c is frequently called an exercise mimetic. The label comes from observations that its levels rise during and after physical activity, and that administering it in animal models reproduces some metabolic effects associated with exercise, such as improved insulin sensitivity and physical capacity. The term mimetic is doing a lot of work, though: it describes overlapping effects in models, not a demonstrated substitute for exercise in humans. Other compounds studied under the exercise-mimetic label, such as AICAR, sit in a similar position.

What the Longevity Research Shows

The findings that draw the most attention come from animal studies. In aged mice, a short course of MOTS-c administration was reported to restore insulin sensitivity toward levels seen in younger animals. Other work reported that treatment later in life improved measures of physical capacity and extended healthspan, the period of life spent in good function, in mice.

These are meaningful preclinical signals, and they are why MOTS-c is grouped with other compounds in aging research. But the distinction between extending healthspan in mice and doing so in humans is large. Mouse longevity findings frequently fail to translate, and the relevant human trials have not been completed. Our overview of peptides and anti-aging research discusses this translation gap, and the same caution that applies to compounds like epithalon applies here.

Where the Evidence Stands

This article is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before making health-related decisions. Clinical trial data referenced here is sourced from peer-reviewed publications and may not reflect the most current findings.